IRIS
PASINI, AUGUSTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 33.543
EU - Europa 2.533
AS - Asia 2.126
SA - Sud America 374
AF - Africa 27
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 8
Totale 38.626
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 33.465
SG - Singapore 1.008
CN - Cina 516
DE - Germania 469
UA - Ucraina 463
BR - Brasile 320
IT - Italia 277
IE - Irlanda 276
SE - Svezia 237
HK - Hong Kong 214
GB - Regno Unito 177
RU - Federazione Russa 163
FR - Francia 132
FI - Finlandia 110
PL - Polonia 101
KR - Corea 93
VN - Vietnam 89
CA - Canada 40
IN - India 39
TW - Taiwan 32
JP - Giappone 30
MX - Messico 29
BE - Belgio 26
CZ - Repubblica Ceca 23
NL - Olanda 21
BD - Bangladesh 19
AR - Argentina 16
ES - Italia 16
TR - Turchia 16
AT - Austria 13
EU - Europa 13
IL - Israele 12
CL - Cile 11
EC - Ecuador 11
ID - Indonesia 10
CO - Colombia 9
CH - Svizzera 8
IQ - Iraq 8
ZA - Sudafrica 8
AU - Australia 6
IR - Iran 6
EG - Egitto 5
MY - Malesia 5
PK - Pakistan 5
AL - Albania 4
KE - Kenya 4
LT - Lituania 4
MA - Marocco 4
PY - Paraguay 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
KZ - Kazakistan 3
PH - Filippine 3
CR - Costa Rica 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GR - Grecia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
RO - Romania 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PR - Porto Rico 1
PT - Portogallo 1
SA - Arabia Saudita 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 38.626
Salva come PNG Salva come JPEG
Città #
Woodbridge 10.394
Wilmington 8.562
Houston 7.767
Fairfield 940
Ann Arbor 901
Chandler 570
Singapore 563
Ashburn 516
Jacksonville 423
Seattle 379
Cambridge 323
Dublin 270
Beijing 256
Hong Kong 213
Medford 205
Dearborn 183
New York 172
Santa Clara 111
Lawrence 100
The Dalles 82
Kraków 75
Los Angeles 72
Mülheim 64
Dallas 60
Rome 54
Menlo Park 50
San Diego 49
Buffalo 48
Redwood City 46
Boardman 41
Council Bluffs 40
Milan 40
Munich 38
Zhengzhou 37
São Paulo 36
Falls Church 35
Ho Chi Minh City 34
Taipei 32
Moscow 31
Norwalk 31
Palo Alto 26
Mountain View 25
Brno 23
Brussels 23
San Mateo 22
Nanjing 21
San Jose 21
Tokyo 20
London 18
Redondo Beach 18
Columbus 17
University Park 17
Chicago 16
Guangzhou 16
Hanoi 16
Kunming 16
Rio de Janeiro 14
Warsaw 14
Toronto 13
Brooklyn 12
Hefei 12
Phoenix 12
Verona 12
Denver 11
Montreal 11
Nanchang 11
Stockholm 11
Washington 11
Brasília 10
Detroit 9
Nuremberg 9
Turku 9
Belo Horizonte 8
Boston 8
Chennai 8
Helsinki 8
Mexico City 8
Nürnberg 8
Poplar 8
Atlanta 7
Catania 7
Hyderabad 7
Indiana 7
Jinan 7
Porto Alegre 7
Saint Petersburg 7
San Francisco 7
Shanghai 7
Amsterdam 6
Auburn Hills 6
Campinas 6
Curitiba 6
Frankfurt am Main 6
Istanbul 6
Osasco 6
Vienna 6
Bologna 5
Da Nang 5
Genoa 5
Guayaquil 5
Totale 34.526
Salva come PNG Salva come JPEG
Nome #
GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment 544
Alexithymia as related to sex, age, and educational level: Results of the Toronto Alexithymia Scale in 417 normal subjects 498
Association between schizohprenia and UFD1L. A developmental gene mapped to chromosome 22 494
Association study of a promoter polymorphism of UFD1L gene with schizophrenia 489
Mirtazapine does not influence tetrahydrodeoxycorticosterone levels in depressed patients 475
Variations in the NMDA receptor subunit 2B gene (GRIN2B) and schizophrenia: a case-control study 473
Human endogenous retroviruses and ADHD 469
Mirtazapine does not influence tetrahydrodeoxycorticosterone levels in depressed patients. 462
Association study between CAG trinucleotide repeats in the PCQAP gene (PC2 glutamine/Q-rich-associated protein) and schizophrenia 458
Variations in the NMDA receptor subunit 2B gene (GRIN2B) and schizophrenia: A case-control study 457
Assessing attentional systems in children with Attention Deficit Hyperactivity Disorder 455
Marked decrease of plasma neuroactive steroids during alcohol withdrawal 454
Neuroleptic treatments and overflow movements in schizophrenia: are they independent? 453
Detecting anxiety symptoms in children and youths with neurofibromatosis type I 452
Patients with deficit, nondeficit, and negative symptom schizophrenia: Do they differ during episodes of acute psychotic decompensation? 450
Assessment of depression in Alzheimer's disease: symptoms, syndrome, and computed tomography findings 449
Residential facilities for older people in Italy: a five-region survey 449
Effects of antidepressant treatment on neuroactive steroids in major depression 446
Fluoxetine decreases concentrations of 3 alpha,5 alpha-tetrahydrodeoxycorticosterone (THDOC) in major depression 445
5-HT2 antagonist ritanserin in neuroleptic-induced parkinsonism: a double-blind comparison with orphenadrine and placebo 445
Lack of potentiation of anticonvulsant effect by fluoxetine in drug-resistant epilepsy 443
Adhd and human endogenous retroviruses 442
Fluoxetine alone in the treatment of first episode anxious-depression: An open clinical trial 439
Impairment in flexible regulation of speed and accuracy in children with ADHD 435
Neurosteroids as neuromodulators in the treatment of anxiety disorders 430
Typical and atypical antipsychotic use in aggressive children and adolescents: A systematic review [Uso degli antipsicotici tipici e atipici nel trattamento dell'aggressività nell'infanzia e nell'adolescenza: Revisione sistematica della letteratura] 428
ALEXITHYMIA AS RELATED TO SEX, AGE, AND EDUCATIONAL-LEVEL - RESULTS OF THE TORONTO ALEXITHYMIA SCALE IN 417 NORMAL SUBJECTS 427
Overflow movements and white matter abnormalities in ADHD 425
Plasma concentrations of neuroactive steroids before and after repetitive transcranial magnetic stimulation (rTMS) in major depression. 423
Alexithymic features in stroke: Effects of laterality and gender 422
Asynchronicity of Organic and Psychiatric Symptoms in a Case of Sertraline Intoxication 422
Neurological soft signs are associated with attentional dysfunction in children with attention deficit hyperactivity disorder 419
Dysfunctional personality traits in adolescence: effects on alerting, orienting and executive control of attention 419
Neuroactive steroids in responders and nonresponders to sleep deprivation 417
Change blindness in children with ADHD: a selective impairment in visual search? 417
Effects of fluoxetine on aggressive behavior of adult inpatients with mental retardation and epilepsy 415
Induced panic attacks shift gamma-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder preliminary results 409
Controlling attention to gaze and arrows in attention deficit hyperactivity disorder 408
Mutations of the Nogo-66 receptor (RTN4R) gene in schizophrenia 407
Pathophysiology of NSS in ADHD 407
Psychiatric symptoms in male cannabis users not using other illicit drugs 407
Timing and clinical characteristics of topiramate-induced psychosis in a patient with epilepsy and tuberous sclerosis 407
Anticonvulsant effect of intranigral fluoxetine 405
Negative symptoms and visual behavior in DSM-III-R prognostic subtypes of schizophreniform disorder 405
Concentrations of 3 alpha-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery 402
Overflow movements and white matter abnormalities in ADHD 401
Increased neurosteroids synthesis after brain and spinal cord injury in rats 400
Plasma concentrations of neuroactive steroids before and after electroconvulsive therapy in major depression 400
Planning deficit in children with neurofibromatosis type 1: a neurocognitive trait independent from attention-deficit hyperactivity disorder (ADHD)? 400
Neuroactive steroid concentrations following metyrapone administration in depressed patients and healthy volunteers 399
Ethological predictors of amitriptyline response in depressed outpatients 398
Attention and executive functions profile in drug naive ADHD subtypes 397
Neurocognitive effects of methylphenidate on ADHD children with different DAT genotypes: a longitudinal open label trial 395
Impaired reflexive orienting to social cues in attention deficit hyperactivity disorder 394
Prefrontal blood flow dysregulation in drug naive ADHD children without structural abnormalities 390
Inhibition of return in response to eye gaze and peripheral cues in young people with Asperger's syndrome 390
Reduced prefrontal cognitive activation associated with aggression in schizophrenia 390
Marked decrease of plasma neuroactive steroids during alcohol withdrawa 387
The complex roles of neurosteroids in depression and anxiety disorders. 385
The neurobiology of attention deficit/hyperactivity disorder. 382
Nonverbal behavior and alexithymic traits in normal subjects. Individual differences in encoding emotions 380
Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3 alpha-hydroxysteroid dehydrogenase activity 379
Altered anandamide degradation in attention-deficit/hyperactivity disorder 378
Panic induction with cholecystokinin-tetrapeptide (CCK-4) increases plasma concentrations of the neuroactive steroid 3 alpha, 5 alpha tetrahydrodeoxycorticosterone (3 alpha, 5 alpha-THDOC) in healthy volunteers 377
Marked decrease of plasma neuroactive steroids during alcohol withdrawal 376
A Small Supernumerary Marker Derived from the Pericentromeric Region of Chromosome 5: Case Report and Delineation of Partial Trisomy 5p Phenotype 375
Paranoid/belligerence and neuroleptic dosage in newly admitted schizophrenic patients 372
Neuroactive steroids are not affected by panic induction with 50 μg cholecystokinin-tetrapeptide (CCK-4) in healthy volunteers [1] 369
Neurological soft signs, but not theory of mind and emotion recognition deficit distinguished children with ADHD from healthy control 369
Fluoxetine and seizures 365
Neuropsychopharmacological properties of neuroactive steroids in depression and anxiety disorders 364
Dopamine dysfunction in 22q11 deletion syndrome: possible cause of motor symptoms 362
Motor examination in children with Attention-deficit/hyperactivity Disorder and Asperger Syndrome 361
Visual search and emotion: how children with autism spectrum disorders scan emotional scenes 361
Is it confirmed the presence of neurological soft signs in children with Neurofibromatosis type 1? 361
Effects of fluoxetine, indomethacine and placebo on 3 alpha, 5 alpha tetrahydroprogesterone (THP) plasma levels in uncomplicated alcohol withdrawal. 358
Effects of combination treatment with mood stabilizers and mirtazapine on plasma concentrations of neuroactive steroids in depressed patients 355
Comorbidity of ADHD and High-functioning Autism: A Pilot Study on the Utility of the Overflow Movements Measure 353
Pathophysiology of NSS in ADHD 352
Ethological assessment of the DSM-III subtyping of unipolar depression 352
Dose-dependent effect of risperidone treatment in a case of 22q13.3 deletion syndrome 350
Changes in CCK-4 induced panic after treatment with the GABA-reuptake inhibitor tiagabine are associated with an increase in 3α,5α-tetrahydrodeoxycorticosterone concentrations 347
The anticonvulsant action of fluoxetine in substantia nigra is dependent upon endogenous serotonin 345
Neurosteroids in developmental disorders 338
Explicit incestuous motifs and emotional crises in psychosomatic patients 337
Neuroactive steroids as modulators of depression and anxiety 336
[Executive function deficits in ADHD and Asperger syndrome] 336
First evidence of HERV-H transcriptional activity reduction after methylphenidate treatment in a young boy with ADHD 328
LE ALLUCINAZIONI 326
5-HT2 receptor antagonism in dysthymic disorder: a double-blind placebo-controlled study with ritanserin 322
Influence of sleep deprivation major depression on neuroactive steroids in major depression 309
Non-verbal behaviour deficits in schizophrenia: an ethological study of drug-free patients 305
Il Delirio 288
Dose-dependent effect of risperidone treatment in a case of 22q13.3 deletion syndrome. 282
I retrovirus endogeni nella sindrome da deficit di attenzione e iperattività (ADHD). 280
Scientific Evidence for the Evaluation of Neurological Soft Signs as Atypical Neurodevelopment Markers in Childhood Neuropsychiatric Disorders 249
The decrease in human endogenous retrovirus-H activity runs in parallel with improvement in ADHD symptoms in patients undergoing methylphenidate therapy 228
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 149
Antipsychotics do not influence neurological soft signs in children and adolescents at ultra-high risk for psychosis: A pilot study 146
Rett syndrome in males: The different clinical course in two brothers with the same microduplication MECP2 Xq28 103
Totale 38.728
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.699
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.699
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.203 0 0 0 0 0 566 645 457 117 128 203 87
2021/20221.082 44 124 97 64 25 125 43 53 76 96 63 272
2022/20231.458 128 91 36 217 144 339 118 98 128 2 126 31
2023/2024518 62 27 43 13 45 178 50 6 4 8 9 73
2024/20251.801 100 462 263 123 50 83 88 110 164 128 132 98
2025/20261.635 360 163 397 266 350 99 0 0 0 0 0 0
Totale 38.765